The two observational studies have limitations, including use of older GLP-1s, but still point to the strengths of bariatric ...

In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

Eli Lilly and Company (NYSE: LLY) has been one of the best-performing stocks outside of the AI-enhanced Magnificent 7 stocks ...

Novo Nordisk's shares rise as Phase III trial shows its oral Wegovy pill achieves significant weight loss, offering a new ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

Whether things are congenial or not, investors have little choice but to step into the arena, no matter what the economic backdrop. Under the current circumstances, sticking with a quality name in ...

In 2015, Julianne Moore won the Academy Award for Best Actress for her starring role in Still Alice, portraying a middle-aged woman diagnosed with early onset Alzheimer’s disease. A decade later, ...

Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...

The Virtus Silvant Focused Growth Fund returned +20.87% (Class INST) for the quarter, compared with the Russell 1000 Growth ...

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...